We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comperative Trial Between an Accommodative Iol and Monofocal Iol

This study has been withdrawn prior to enrollment.
(Company could not supply the accommodating intraocular lenses for the study)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00604305
First Posted: January 30, 2008
Last Update Posted: June 12, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Dr. Yaacov Rozenman, Shaare Zedek Medical Center
  Purpose
a comparison of two intraocular lenses in regard of accommodative power.

Condition Intervention
CATARACT SURGERY Device: Acrysof Device: Acuity's AIOL

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Randomized Single Blind Comparative Study of the Acuity's C-Well Accommodating Intra Occular Lens (AIOL) Against Alcon's Acrysof

Further study details as provided by Dr. Yaacov Rozenman, Shaare Zedek Medical Center:

Primary Outcome Measures:
  • distance and near visual acuity [ Time Frame: 1 year ]

Secondary Outcome Measures:
  • centration pco [ Time Frame: 1 year ]

Enrollment: 0
Study Start Date: March 2008
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Acrysof
Routine monofocal IOL
Device: Acrysof
Monofocal IOL
Active Comparator: Acuity's AIOL
Accomodaing IOL
Device: Acuity's AIOL
Accommodating IOL

Detailed Description:
A new accommodating IOL (Acuity Ltd, Israel) will be compared with Alcon's Acrysof for 1 year for visual acuity and distance and near best corrected visual acuity.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   30 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age between 30 and 65
  • Required cataract operation in one or both eyes
  • BCVA potetial at least 20/30
  • Clear intraoccular media
  • Willing to participate in study as evidenced by signing a written Informed Consent

Exclusion Criteria:Main

  • Prior surgery at the selected eye
  • No light perception or poor potential for improvement
  • Phacodonesis and damaged zonules
  • Pupil size at least 6 mm.
  • History of uveitis
  • Macular disease decreasing vision below 20/30
  • Amblyopia
  • Axial length shorter than 21 mm and longer than 25 mm
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: Dr. Yaacov Rozenman, Head of eye department, Shaare Zedek Medical Center
ClinicalTrials.gov Identifier: NCT00604305     History of Changes
Other Study ID Numbers: 6666476CTIL
Rozenman-CWPMS001
First Submitted: January 17, 2008
First Posted: January 30, 2008
Last Update Posted: June 12, 2012
Last Verified: June 2012

Additional relevant MeSH terms:
Cataract
Lens Diseases
Eye Diseases